ProFunds Biotechnology UltraSector Fund

Scorecard
3 / 5 Stars
Lipper
5 3 1 3 1
Zacks Investment Research
1 (Strong Buy)
Standard & Poor's
5 / 5 Stars
TheStreet.com
C (Hold)

Fund Fees

Updated 12.01.2013

Maximum Sales Fees %
Initial
Deferred

Updated 12.01.2013

Maximum Fees %
Administrative 0.05
Management 0.75
Redemption

Updated 12.01.2013

Actual Fees %
12b-1 1.0
Management 0.75
Net Expense Ratio: Annual Report 2.68
Net Expense Ratio: Prospectus 2.65

Updated 07.03.2014

Total Cost Projections
3-Year $823.00
5-Year $1,405.00
10-Year $2,983.00

Purchase Information

Updated 12.01.2013

Minimum Investments
Initial $15,000.00
Additional
Initial IRA $15,000.00
Additional IRA
Initial AIP $15,000.00
Additional AIP